Furthermore, the blockade of IL−6R signaling has been implicated in increased liver fibrosis [28,29] and enhanced hepatic steatosis while reducing liver injury [30] suggesting IL−6 signaling may attenuate liver fibrosis. This evidence concerns the gene IL6 and Hepatic fibrosis.